Medoxem

Cefuroxime sodium, the active ingredient in Medoxem, is a second‑generation cephalosporin presented as an injectable solution for intramuscular and intravenous use. It treats a range of bacterial infections in adults and children when prescribed by a healthcare professional.

GNH USA supplies Medoxem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Cefuroxime sodium is indicated for bacterial infections affecting various organ systems and is administered by injection.

- Respiratory tract infections: effective against common pathogens causing community‑acquired pneumonia and bronchitis. - Urinary tract infections: treats uncomplicated and complicated infections caused by susceptible bacteria. - Skin and soft‑tissue infections: resolves cellulitis, abscesses, and wound infections. - Meningitis: provides bactericidal activity against causative organisms in acute bacterial meningitis. - Gonorrhoea: used for uncomplicated gonococcal infections caused by susceptible strains.

Cefuroxime sodium may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Injection site pain: local discomfort at the site of administration. - Diarrhoea: loose stools that may be mild to moderate. - Nausea: feeling of queasiness often without vomiting. - Rash: mild skin erythema or itching.

Serious or Rare Side Effects: - Anaphylaxis: severe, potentially life‑threatening allergic reaction. - Stevens‑Johnson syndrome: rare severe skin and mucous membrane disorder. - Clostridioides difficile‑associated colitis: severe intestinal inflammation. - Hemolytic anemia: destruction of red blood cells leading to anemia.

Before using Cefuroxime sodium, consider the following safety measures.

- Allergy assessment: verify no known hypersensitivity to cephalosporins or penicillins. - Renal function monitoring: evaluate kidney function, especially in patients with impairment. - Dose adjustment: modify dosage in patients with reduced renal clearance. - History of colitis: use with caution in individuals with prior C. difficile infection. - Concomitant nephrotoxins: avoid or monitor when combined with other kidney‑affecting drugs. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Cefuroxime sodium can interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - Probenecid: reduces renal excretion, increasing cefuroxime levels. - Live vaccines: may diminish vaccine efficacy or increase infection risk. - Warfarin: potentiates anticoagulant effect, raising bleeding risk. - Aminoglycosides: additive nephrotoxicity when used together.

Moderate Interactions (Monitor Closely): - Diuretics: may affect renal clearance of cefuroxime. - Oral contraceptives: possible reduction in contraceptive effectiveness. - Antacids containing aluminium or magnesium: may alter absorption if oral formulation were used.